|
1
|
Chen YK, Huang HC, Lin LM and Lin CC:
Primary oral squamous cell carcinoma: An analysis of 703 cases in
southern Taiwan. Oral Oncol. 35:173–179. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sano D and Myers JN: Metastasis of
squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev.
26:645–662. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Greene FL, Page DL, Fleming ID, et al:
AJCC Cancer Staging Hhandbook. 6th. New York: Springer-Verlag; pp.
35–46. 2002
|
|
4
|
Ota T, Suzuki Y, Nishikawa T, Otsuki T,
Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al:
Complete sequencing and characterization of 21,243 full-length
human cDNAs. Nat Genet. 36:40–45. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen Y, Cha Z, Fang W, Qian B, Yu W, Li W,
Yu G and Gao Y: The prognostic potential and oncogenic effects of
PRR11 expression in hilar cholangiocarcinoma. Oncotarget.
6:20419–20433. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tai YC, Domchek S, Parmigiani G and Chen
S: Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.
J Natl Cancer Inst. 99:1811–1814. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yan J, Jiang J, Lim CA, Wu Q, Ng HH and
Chin KC: BLIMP1 regulates cell growth through repression of p53
transcription. Proc Natl Acad Sci USA. 104:1841–1846. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji Y, Xie M, Lan H, Zhang Y, Long Y, Weng
H, Li D, Cai W, Zhu H, Niu Y, et al: PRR11 is a novel gene
implicated in cell cycle progression and lung cancer. Int J Biochem
Cell Biol. 45:645–656. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou F, Liu H, Zhang X, Shen Y, Zheng D,
Zhang A, Lai Y and Li H: Proline-rich protein 11 regulates
epithelial-to-mesenchymal transition to promote breast cancer cell
invasion. Int J Clin Exp Pathol. 7:8692–8699. 2014.PubMed/NCBI
|
|
10
|
Song Z, Liu W, Xiao Y, Zhang M, Luo Y,
Yuan W, Xu Y, Yu G and Hu Y: PRR11 is a prognostic marker and
potential oncogene in patients with gastric cancer. PLoS One.
10:e1289432015.
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song L, Gong H, Lin C, Wang C, Liu L, Wu
J, Li M and Li J: Flotillin-1 promotes tumor necrosis factor-α
receptor signaling and activation of NF-κB in esophageal squamous
cell carcinoma cells. Gastroenterology. 143:995–1005.e12. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Yu L, Zhang H, Wu J, Yuan J, Li X
and Li M: Down-regulation of pescadillo inhibits proliferation and
tumorigenicity of breast cancer cells. Cancer Sci. 100:2255–2260.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ball LJ, Kühne R, Schneider-Mergener J and
Oschkinat H: Recognition of proline-rich motifs by
protein-protein-interaction domains. Angew Chem Int Ed Engl.
44:2852–2869. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sera T: Zinc-finger-based artificial
transcription factors and their applications. Adv Drug Deliv Rev.
61:513–526. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao Q: RNAi-mediated silencing of
praline-rich gene causes growth reduction in human lung cancer
cells. Int J Clin Exp Pathol. 8:1760–1767. 2015.PubMed/NCBI
|
|
17
|
Wang Y, Zhang Y, Zhang C, Weng H, Li Y,
Cai W, Xie M, Long Y, Ai Q, Liu Z, et al: The gene pair PRR11 and
SKA2 shares a NF-Y-regulated bidirectional promoter and contributes
to lung cancer development. Biochim Biophys Acta. 1849:1133–1144.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang C, Zhang Y, Li Y, Zhu H, Wang Y, Cai
W, Zhu J, Ozaki T and Bu Y: PRR11 regulates late-S to G2/M phase
progression and induces premature chromatin condensation (PCC).
Biochem Biophys Res Commun. 458:501–508. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dooley AL, Winslow MM, Chiang DY, Banerji
S, Stransky N, Dayton TL, Snyder EL, Senna S, Whittaker CA, Bronson
RT, et al: Nuclear factor I/B is an oncogene in small cell lung
cancer. Genes Dev. 25:1470–1475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu AW, Cai J, Zhao XL, Jiang TH, He TF,
Fu HQ, Zhu MH and Zhang SH: ShRNA-targeted MAP4K4 inhibits
hepatocellular carcinoma growth. Clin Cancer Res. 17:710–720. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Malumbres M and Carnero A: Cell cycle
deregulation: A common motif in cancer. Prog Cell Cycle Res.
5:5–18. 2003.PubMed/NCBI
|
|
22
|
Yageta M, Kuramochi M, Masuda M, Fukami T,
Fukuhara H, Maruyama T, Shibuya M and Murakami Y: Direct
association of TSLC1 and DAL-1, two distinct tumor suppressor
proteins in lung cancer. Cancer Res. 62:5129–5133. 2002.PubMed/NCBI
|
|
23
|
Bernkopf DB and Williams ED: Potential
role of EPB41L3 (protein 4.1B/Dal-1) as a target for treatment of
advanced prostate cancer. Expert Opin Ther Targets. 12:845–853.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Collins CS, Hong J, Sapinoso L, Zhou Y,
Liu Z, Micklash K, Schultz PG and Hampton GM: A small interfering
RNA screen for modulators of tumor cell motility identifies MAP4K4
as a promigratory kinase. Proc Natl Acad Sci USA. 103:3775–3780.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei
Y, Abbruzzese JL, Hortobagyi GN and Hung MC: Epidermal growth
factor receptor cooperates with signal transducer and activator of
transcription 3 to induce epithelial-mesenchymal transition in
cancer cells via up-regulation of TWIST gene expression. Cancer
Res. 67:9066–9076. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rusthoven K, Ballonoff A, Raben D and Chen
C: Poor prognosis in patients with stage I and II oral tongue
squamous cell carcinoma. Cancer. 112:345–351. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Byers RM, El-Naggar AK, Lee YY, Rao B,
Fornage B, Terry NH, Sample D, Hankins P, Smith TL and Wolf PJ: Can
we detect or predict the presence of occult nodal metastases in
patients with squamous carcinoma of the oral tongue? Head Neck.
20:138–144. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
D'Cruz AK, Siddachari RC, Walvekar RR,
Pantvaidya GH, Chaukar DA, Deshpande MS, Pai PS and Chaturvedi P:
Elective neck dissection for the management of the N0 neck in early
cancer of the oral tongue: Need for a randomized controlled trial.
Head Neck. 31:618–624. 2009. View Article : Google Scholar : PubMed/NCBI
|
